Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) [clinicaltrials_resource:5ef9a269681d260cdc60f0b4d4cf9c1e]
Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia [clinicaltrials:NCT00003190]Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer [clinicaltrials:NCT00005799]Radiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First Remission [clinicaltrials:NCT00005940]Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00006363]Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes [clinicaltrials:NCT00008177]Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer [clinicaltrials:NCT00012376]Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies [clinicaltrials:NCT00014235]Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia [clinicaltrials:NCT00027872]Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer [clinicaltrials:NCT00039091]Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00039117]Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies [clinicaltrials:NCT00040846]A Phase II Study Of The Farnesyltransferase Inhibitor ZANESTRA (R115777, NSC #702818, IND #58,359) In Complete Remission Following Induction And/Or Consolidation Chemotherapy In Adults With Poor-Risk Acute Myelogenous Leukemia (AML) And High-Risk Myelodysplasia (MDS) [clinicaltrials:NCT00045396]Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission [clinicaltrials:NCT00045435]clinicaltrials:NCT00049504Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia [clinicaltrials:NCT00049582]clinicaltrials:NCT00052520clinicaltrials:NCT00052598Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer [clinicaltrials:NCT00060372]Romidepsin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [clinicaltrials:NCT00062075]GTI-2040 and High-Dose Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia [clinicaltrials:NCT00070551]3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies [clinicaltrials:NCT00077181]Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant [clinicaltrials:NCT00078858]Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [clinicaltrials:NCT00079378]CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase [clinicaltrials:NCT00084916]Daunorubicin Hydrochloride, Cytarabine and Oblimersen Sodium in Treating Patients With Previously Untreated Acute Myeloid Leukemia [clinicaltrials:NCT00085124]Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia [clinicaltrials:NCT00087204]Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer [clinicaltrials:NCT00089011]S0432 Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00093418]Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia [clinicaltrials:NCT00093743]XK469R in Treating Patients With Refractory Hematologic Cancer [clinicaltrials:NCT00095797]clinicaltrials:NCT00096122Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes [clinicaltrials:NCT00098423]SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes [clinicaltrials:NCT00098826]Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia [clinicaltrials:NCT00101231]Tipifarnib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [clinicaltrials:NCT00101296]17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic Cancer [clinicaltrials:NCT00103272]Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer [clinicaltrials:NCT00112593]Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia [clinicaltrials:NCT00112853]Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00119366]Sorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia [clinicaltrials:NCT00131989]
condition [clinicaltrials_vocabulary:condition]
Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) [clinicaltrials_resource:5ef9a269681d260cdc60f0b4d4cf9c1e]
Bio2RDF identifier
5ef9a269681d260cdc60f0b4d4cf9c1e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:5ef9a269681d260cdc60f0b4d4cf9c1e
identifier
clinicaltrials_resource:5ef9a269681d260cdc60f0b4d4cf9c1e
title
Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)
@en
label
Adult Acute Myeloid Leukemia W ...... 9a269681d260cdc60f0b4d4cf9c1e]
@en